Home
>
National Drug Code (NDC)
>
Methotrexate
Methotrexate - 61703-408-41 - (METHOTREXATE SODIUM)
Drug Information of Methotrexate
| Product NDC: | 61703-408 |
| Proprietary Name: | Methotrexate |
| Non Proprietary Name: | METHOTREXATE SODIUM |
| Active Ingredient(s): | 25 mg/mL & nbsp; METHOTREXATE SODIUM |
| Administration Route(s): | INTRA-ARTERIAL; INTRAMUSCULAR; INTRATHECAL; INTRAVENOUS |
| Dosage Form(s): | INJECTION, SOLUTION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Methotrexate
| Product NDC: | 61703-408 |
| Labeler Name: | Hospira Worldwide, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA011719 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20050413 |
Package Information of Methotrexate
| Package NDC: | 61703-408-41 |
| Package Description: | 1 VIAL in 1 CARTON (61703-408-41) > 40 mL in 1 VIAL |
NDC Information of Methotrexate
| NDC Code | 61703-408-41 |
| Proprietary Name | Methotrexate |
| Package Description | 1 VIAL in 1 CARTON (61703-408-41) > 40 mL in 1 VIAL |
| Product NDC | 61703-408 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | METHOTREXATE SODIUM |
| Dosage Form Name | INJECTION, SOLUTION |
| Route Name | INTRA-ARTERIAL; INTRAMUSCULAR; INTRATHECAL; INTRAVENOUS |
| Start Marketing Date | 20050413 |
| Marketing Category Name | NDA |
| Labeler Name | Hospira Worldwide, Inc. |
| Substance Name | METHOTREXATE SODIUM |
| Strength Number | 25 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes | Folate Analog Metabolic Inhibitor [EPC],Folic Acid Metabolism Inhibitors [MoA] |
